Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,857.5
-12.1 (-0.42%)

 

  • STI Straits Times Index
    2,857.5
    -12.1 (-0.42%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,612.1
    14.5 (0.91%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,819.5
    149.7 (0.56%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,369.7
    7.4 (0.22%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    26,537.3
    240.5 (0.91%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,759.9
    80.7 (1.42%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,755.8M
  • Value: 1,236.9M
  • Rise: 180
  • Fall: 128
  • Unch: 466

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.169+0.003
Oceanus^0.027+0.003
LionGold0.003-
QT Vascular0.007+0.001
Jiutian Chemical0.087+0.001
Rex Intl0.158+0.003
Aspen0.275+0.020
Intl Cement0.069+0.004
ThaiBev0.745+0.025
Lippo Malls Tr0.093+0.001

World Indices

World Indices
Name Last Change
Nasdaq 11,553.9 -159.9
HSI 26,289.5 -12.0
HSCEI 10,572.1 -14.8
Jakarta 5,503.6 +40.9
Nikkei 225 25,349.6 +444.0
SSE Comp 3,342.2 -17.9
Shanghai A 3,502.9 -18.8
Shanghai B 251.2 -0.9
KOSPI 2,485.9 +33.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

UGHealthcare UG HEALTHCARE CORPORATIONLTD
Quotes 10 Minutes Delayed. Updated at 26 Nov 2020 17:15
Last (SGD): 0.715 Change: +0.065 High: 0.730 Remarks: -
Change (%): +10.00 Low: 0.655
Open 0.660 Yesterday's Close 0.650
Buy Price 0.715 Sell Price 0.720
Buy Volume ('000) 91.7 Sell Volume ('000) 617.0
Cumulative Volume ('000) 14,440.7 Cumulative Value 10,141,435
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.02179 Trailing EPS (SGD) e 0.02179 NAV (SGD) b 0.1160
PE a 32.813 Trailing PE f 32.809 Price / NAV b 6.1638
Dividend (SGD) d , k 0.002277 Cash In Hand (SGD) g 0.0141 Issued & Paid-up Shares c 614,979,000
Dividend Yield (%) d , k 0.318 Price / Cash In Hand g 50.709 Treasury Shares h -
Beta - 75 Daysi -1.344 R-Squared - 75 Days(%)i 3.51 Market Cap (M) 439.710
Beta - 500 Daysi -0.001 R-Squared - 500 Days (%)i - Enterprise Value (M) 468.006
Piotroski F Score 7 Exchange Code 8K7 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 121.374 6-Month VWAP 0.533 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Oct 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.
  10. Adjusted based on Full Year Jun 2020: Annual Dividend of SG 0.7140 cents declared was based on pre-split shares. Final Dividend to be paid has been revised from SG 0.7140 cents to SG 0.2380 cents per post-split share.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference UGHealthcare SGX 439.710 32.813 32.809 6.1638 0.318
Industry Medical & Biotechnology SGX 905.455 21.542 20.796 1.2894 2.120
Medical Specialties SGX 4,126.446 40.361 36.965 13.1486 1.270
Index FTSE ST Catalist Index SGX 64.361 30.063 88.683 1.1077 1.721
Local Peer Top Glove SGX 18,815.729 30.989 30.990 11.6129 1.658
Local Peer Medtecs Intl SGX 535.676 342.105 9.700 3.7923 -
Local Peer Biolidics SGX 81.855 - - 7.5980 -
Local Peer Yunnan Energy SGX 35.531 - - 0.7346 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer ABBOTT LABORATORIES NYSE 188,596.828 51.445 56.382 6.0089 1.234
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 177,736.431 48.089 36.429 5.5850 0.171
Global Peer DANAHER CORP NYSE 154,308.092 62.001 49.536 4.4478 0.306
Global Peer MEDTRONIC PLC NYSE 152,464.271 31.836 34.527 3.0313 1.970
Global Peer STRYKER CORP NYSE 87,829.873 42.165 50.017 6.7634 0.910
Global Peer INTUITIVE SURGICAL INC NASDAQ 85,388.425 61.907 81.083 9.2234 -
Global Peer BECTON DICKINSON & CO NYSE 65,973.352 86.015 85.967 2.7749 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 52,483.714 50.132 66.092 12.4656 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 48,040.916 10.221 13.037 3.0867 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 46,235.940 35.398 41.498 3.7588 1.802
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), DEXCOM INC (NASDAQ), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), INSULET CORPORATION (NASDAQ), STERIS PLC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), WATERS CORP (NYSE), TOPGLOV (Bursa), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), HARTA (Bursa), ABIOMED INC (NASDAQ), NOVOCURE LTD (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), WEIGAO GROUP (HKEx), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), QUIDEL CORP (NASDAQ), MICROPORT (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), TANDEM DIABETES CARE INC (NASDAQ), SUPERMX (Bursa), INSPIRE MEDICAL SYSTEMS INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), VENUS MEDTECH-B (HKEx), INARI MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), CAREDX INC (NASDAQ), LIVANOVA PLC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), NUVASIVE INC (NASDAQ), KANGJI MEDICAL (HKEx), NANO-X IMAGING LTD (NASDAQ), AVANOS MEDICAL INC (NYSE), ATRICURE INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), PULMONX CORPORATION (NASDAQ), BIOTELEMETRY INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), EARGO INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AK MEDICAL (HKEx), PEIJIA-B (HKEx), LIFETECH SCI (HKEx), INMODE LTD (NASDAQ), NANOSONICS LIMITED (ASX), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), MESA LABORATORIES INC (NASDAQ), HESKA CORP (NASDAQ), CIRC (HKEx), VERICEL CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), KDL MEDICAL (HKEx), LEMAITRE VASCULAR INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), ORASURE TECHNOLOGIES INC (NASDAQ), INOGEN INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), SI BONE INC (NASDAQ), QUOTIENT LTD (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), VAPOTHERM INC (NYSE), AXOGEN INC (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CORMEDIX INC (NYSE American), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), ZYNEX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CUTERA INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), PW MEDTECH (HKEx), ACCURAY INCORPORATED (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), YESTAR HEALTH (HKEx), PULSE BIOSCIENCES INC (NASDAQ), PROFOUND MED CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), INVACARE CORP (NYSE), MEDICAL DEVELOPMENT INTL (ASX), IRADIMED CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AROA BIOSURGERY LTD (ASX), SIENTRA INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), DERMTECH INC (NASDAQ), MISONIX INC (NASDAQ), TELA BIO INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), REPRO MEDSYSTEMS INC (NASDAQ), ALPHA PRO TECH (NYSE American), SURGALIGN HOLDINGS INC (NASDAQ), SOLITON INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), MODERN DENTAL (HKEx), NEURONETICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), INTRICOM CORP (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), FONAR CORP (NASDAQ), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), PAVMED INC (NASDAQ), LENSAR INC (NASDAQ), LKL (Bursa), NEMAURA MEDICAL INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), ROCKWELL MEDICAL INC (NASDAQ), MICRO-X LTD (ASX), VOLITIONRX LIMITED (NYSE American), RESPIRI LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TITAN MEDICAL INC (NASDAQ), ELECTROMED INC (NYSE American), BIOMERICA INC (NASDAQ), KELFRED (HKEx), APOLLO ENDOSURGERY INC (NASDAQ), COMPUMEDICS (ASX), SDI LTD (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), NEPHROS INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), RESONANCE HEALTH LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), STRATA SKIN SCIENCES INC (NASDAQ), CONFORMIS INC (NASDAQ), DAXOR CORP (NYSE American), ONCOCYTE CORP (NYSE American), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), RESAPP HEALTH LIMITED (ASX), SINTX TECHNOLOGIES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), OPTISCAN IMAGING (ASX), IMMUCELL CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), APPLIED UV INC (NASDAQ), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), CARDIEX LTD (ASX), OVENTUS MEDICAL LTD (ASX), LIFE HEALTHCARE (HKEx), BIOLASE INC (NASDAQ), LBT INNOVATIONS LTD (ASX), REWALK ROBOTICS LTD (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AVINGER INC (NASDAQ), NEUROTROPE INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), IRIDEX CORP (NASDAQ), METALICITY LIMITED (ASX), XTANT MEDICAL HLDGS INC (NYSE American), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), CELSION CORPORATION (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), THERMOGENESIS HOLDINGS INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), USCOM LTD (ASX), NEOVASC INC (NASDAQ), CHECK-CAP LTD (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), ADHERIUM LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), DIGIRAD CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), DYNATRONICS CORP (NASDAQ), CANCER GENETICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), ANALYTICA (ASX), NEUROMETRIX INC (NASDAQ), DORSAVI LTD (ASX), OBALON THERAPEUTICS INC (NASDAQ), HUAKANG BIOMED (HKEx), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.040
+5.93 %
10 Days -+0.075
+11.72 %
20 Days 0.002-0.205
-22.07 %
Medium Term Return 3 Months 0.002-0.055
-6.88 %
6 Months 0.002+0.565
+378.00 %
1 Year 0.002+0.665
+1334.00 %
Long Term Return 2 Years 0.005+0.638
+835.06 %
3 Years 0.007+0.645
+931.43 %
5 Years 0.013+0.543
+323.26 %
Annualised Return Annualised --
+33.45 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.044 - 1.147 Change From 1 Year Low +0.671 % Change From 1 Year Low (%) +1536.16
Change From 1 Year High -0.432 % Change From 1 Year High (%) -37.65
2 Years Range 0.044 - 1.147 Change From 2 Years Low +0.671 % Change From 2 Years Low (%) +1536.16
Change From 2 Years High -0.432 % Change From 2 Years High (%) -37.65
5 Years Range 0.044 - 1.147 Change From 5 Years Low +0.671 % Change From 5 Years Low (%) +1536.16
Change From 5 Years High -0.432 % Change From 5 Years High (%) -37.65
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

UG Healthcare Corporation Limited ???????? (UG Healthcare and together with its subsidiaries, the Group), is a disposable gloves manufacturer with its own established global downstream distribution that markets and sells disposable glove products under its proprietary Unigloves brand. The Group owns and operates an extensive downstream network of distribution companies with a local presence in Europe, United Kingdom, USA, China, Africa, South America, Japan, Korea and Canada, where it markets and sells its own proprietary Unigloves brand of disposable gloves. The Group also distributes ancillary products including surgical gloves, vinyl and cleanroom disposable gloves, face masks and other medical disposables. These downstream distribution companies are supported and complemented by the Groups own upstream manufacturing division, manufacturing natural latex and nitrile disposable gloves under its Unigloves brand and third party labels in its manufacturing facilities located in Seremban, Malaysia. Its Unigloves brand of disposable gloves offers an extensive product range that includes both specialised products, with a variety of coatings, scents, colours, thickness, anti-microbial properties for more specialised users, as well as generic products. These products are used across a diverse range of industries requiring cross infection protection and hygiene standards, whilst catering to different applications and preferences.For more information, please visit the companys website at www.ughealthcarecorporation.com

IPO Performance

Listing Date 08 Dec 2014 Full Subscription Rate (x) 11.51
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 1.80 Public Offer Subscription Rate (x) 169.08
IPO Price (SGD) a 0.072 First Day Close (SGD) a 0.083 First Week Close (SGD) a 0.077
Current vs IPO Price (%) +893.06 First Day Gain (%) +15.28 First Week Gain (%) +6.94
Notes:
  1. Adjusted for the following: Share Split 3 for 1 on 30/09/2020

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2020 Jun 2020 Part 1(3.07 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
26 Nov 2020 0.660 0.730 0.655 0.715 14,440,700 0.7023
25 Nov 2020 0.670 0.675 0.650 0.650 3,218,100 0.6614
24 Nov 2020 0.690 0.690 0.660 0.665 5,705,700 0.6742
23 Nov 2020 0.695 0.705 0.675 0.680 4,882,500 0.6856
20 Nov 2020 0.685 0.705 0.680 0.680 5,831,400 0.6917
19 Nov 2020 0.705 0.705 0.675 0.675 3,306,600 0.6874
18 Nov 2020 0.730 0.730 0.695 0.705 3,991,600 0.7085
17 Nov 2020 0.675 0.730 0.670 0.705 14,153,000 0.7088
16 Nov 2020 0.795 0.820 0.730 0.740 22,005,300 0.7822
13 Nov 2020 0.660 0.765 0.660 0.765 15,385,200 0.7219
12 Nov 2020 0.730 0.735 0.620 0.640 13,481,900 0.6616
11 Nov 2020 0.815 0.825 0.715 0.735 14,974,300 0.7519
10 Nov 2020 0.860 0.865 0.800 0.805 23,532,700 0.8238
09 Nov 2020 0.975 0.990 0.970 0.970 4,100,000 0.9763
06 Nov 2020 0.995 1.010 0.960 0.965 12,640,100 0.9844
05 Nov 2020 0.975 0.985 0.965 0.980 8,579,000 0.9774
04 Nov 2020 0.920 0.975 0.910 0.955 10,716,600 0.9488
03 Nov 2020 0.905 0.925 0.905 0.915 3,236,800 0.9137
02 Nov 2020 0.910 0.920 0.895 0.905 4,090,200 0.9047
30 Oct 2020 0.920 0.925 0.900 0.905 2,264,900 0.9099
29 Oct 2020 0.895 0.930 0.890 0.920 5,035,700 0.9187
28 Oct 2020 0.935 0.935 0.890 0.895 4,331,100 0.9096
Summary
Current 2 Weeks
(13 Nov 2020 to 26 Nov 2020)
0.660 0.820 0.650 0.715 92,920,100 -
Previous 2 Weeks
(30 Oct 2020 to 12 Nov 2020)
0.920 0.925 0.650 0.640 97,616,500 -
4 Weeks from
(02 Oct 2020 to 29 Oct 2020)
0.845 0.940 0.650 0.920 253,583,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.